Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis
View Patent ↗The invention relates to the production of ovoproducts containing bioactive peptides from the egg white subjected to enzymatic treatment. Said peptides have an inhibiting activity of the angiotensin converting enzyme (ACE inhibiting activity) in vitro and/or anti-hypertensive activity in rats and/or antioxidant activity. Said ovoproducts, complete hydrolyzates, the fractions thereof with low molecular weight or their constituent peptides could be used as therapeutic substances with ACE inhibiting activity and/or anti-hypertensive activity and/or anti-oxidant activity, either as functional food products, food additives or ingredients or pharmaceutical products for the treatment and/or prevention of hypertension in all its forms in humans or animals and for the treatment and/or prevention of any disorder associated with hypertension in humans or animals.
1. An isolated bioactive product wherein said product:
a) is an isolated peptide sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8;
b) has a molecular weight between 365.2 and 1152.58 Da;
c) is obtained from the amino acid positions 36-126 of the amino acid sequence of ovalbumin or is synthesized by solid phase peptide synthesis; and
d) possesses ACEI activity in vitro and/or possesses anti-hypertensive activity in spontaneous hypertensive rats in vivo.
2. The isolated bioactive product according to claim 1 wherein said product obtained from the amino acid sequence of ovalbumin is obtained by means of recombinant methods.
3. The isolated bioactive product according to claim 1 wherein said product is obtained by a method comprising:
a) obtaining from an animal or from a microorganism a substrate containing ovalbumin;
b) contacting the substrate containing ovalbumin with pepsin at pH 2.0-3.0, for a period of time between 10 minutes and 24 hours, and a temperature sufficient to enzymatically hydrolyze the ovalbumin, thereby obtaining a hydrolysate, wherein said hydrolysate contains a peptide selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8;
c) dissolving or dispersing the hydrolysate in water or buffer solution; and
d) isolating from the dissolved or dispersed hydrolysate of step (c) a peptide from the group consisting of SEQ ID NO: 1, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8.
4. The isolated bioactive product according to claim 3 wherein the substrate containing ovalbumin defined in step (a) of claim 3 is selected from the group consisting of pure ovalbumin, egg white, and ovoproducts intended for the catering and restaurant trade, for dietary complements for sportsmen, or for animal food.
5. The isolated bioactive product according to claim 3 wherein the period of time defined in step (b) of claim 5 is less than 3 hours.
6. A composition consisting essentially of the isolated peptide sequence according to claim 1 and pharmaceutically acceptable salts thereof, the peptide sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8.